Exchange: NASDAQ·Updated 07:52 PM EDT

About MIST

About

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone’s lead product is CARDAMYST® (etripamil) nasal spray, a novel calcium channel blocker, which is FDA-approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in Phase 3 development for the control of symptomatic episodic attacks associated with AFib-RVR. https://milestonepharma.com/
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
38

Frequently Asked Questions

What is Market Cap of Milestone Pharmaceuticals Inc?
What is the 52-week high for Milestone Pharmaceuticals Inc?
What is the 52-week low for Milestone Pharmaceuticals Inc?
What is Milestone Pharmaceuticals Inc stock price today?
What was Milestone Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Milestone Pharmaceuticals Inc?
What is the Price-to-Book ratio of Milestone Pharmaceuticals Inc?
What is the 50-day moving average of Milestone Pharmaceuticals Inc?
How many employees does Milestone Pharmaceuticals Inc have?

Advertisement|Remove ads.